All entries for: Oncology

May 9, 2023

IDEAYA Biosciences

Negative Outlook

San Francisco, CA
51-200 employees
51-200 employees
Disease Area: Oncology
Drug Type: Small Molecule
May 9, 2023

Halozyme Therapeutics

Negative Outlook

San Diego, CA
201-500 employees
201-500 employees
Disease Area: Oncology
Drug Type: Biologic
May 9, 2023

Exelixis

Negative Outlook

Alameda, CA
1,001-5,000 employees
1001-5000 employees
Disease Area: Oncology
Drug Type: Small Molecule
May 9, 2023

CytomX Therapeutics

Negative Outlook

San Francisco, CA
51-200 employees
51-200 employees
Disease Area: Oncology
Drug Type: Biologic
May 8, 2023

Zymeworks

Negative Outlook

Middletown, DE
201-500 employees
201-500 employees
Disease Area: Multiple, Oncology, Therapeutics
Drug Type: Biologic
May 8, 2023

Recursion Pharmaceuticals

Neutral Outlook

Salt Lake City, UT
201-500 employees
201-500 employees
Disease Area: Multiple, Oncology
Drug Type: Biologic, Small Molecule
May 8, 2023

Coherus BioSciences

Negative Outlook

Camarillo, CA
201-500 employees
201-500 employees
Disease Area: Oncology
Drug Type: Biologic
May 5, 2023

AbbVie 

Negative Outlook

Chicago, IL
50,001+ employees
50001+ employees
Disease Area: Oncology
Drug Type: Biologic
May 5, 2023

Merck

Negative Outlook

Rahway, NJ
50,001+ employees
50001+ employees
Disease Area: Oncology
Drug Type: Biologic, Small Molecule
May 4, 2023

Beigene

Negative Outlook

Cambridge, MA
5,001-10,000 employees
5001-10000 employees
Disease Area: Oncology
Drug Type: Biologic
Scroll to Top